SCHEMBL13159672

SCHEMBL13159672

Cc1cccc([C@@H](C)CO)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 4/20 0.42
ADRA2B P18089 4/20 0.42
ADRA2C P18825 4/20 0.42
ADRA1A P35348 3/20 0.42
ADRA1B P35368 3/20 0.42
TSHR P16473 3/20 0.42
CYP1A2 P05177 3/20 0.42
ADRA1D P25100 2/20 0.42
CYP3A4 P08684 2/20 0.42
KCNH2 Q12809 1/20 0.42
TP53 P04637 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GABRA1 P14867 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
TRPA1 O75762 3/20 0.41
ATM Q13315 1/20 0.41
SLC6A2 P23975 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18793782 1.00 ADRA2A (0.42) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL375325 1.00 ADRA2A (0.42) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL17963769 0.84 ADRA2A (0.40) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL593086 0.83 ESR1 (0.46) TSHRCYP1A2GABRA1GABRG2GABRB3
SCHEMBL27391011 0.81 TSHR (0.52) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL20738578 0.80 GABRA1 (0.39) ADRA2AADRA2BADRA2CTSHRCYP1A2
SCHEMBL9558664 0.79 ADRA2A (0.42) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL25303539 0.79 ADRA2A (0.39) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL16952251 0.78 TRPA1 (0.40) ADRA2AADRA2BADRA2CADRA1AADRA1B
SCHEMBL29337470 0.78 TRPA1 (0.40) ADRA2AADRA2BADRA2CADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed